+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Image Guided Surgery Devices Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 160 Pages
  • July 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855122
The global image guided surgery devices market attained a value of USD 7 billion in 2022, driven by increasing adoption of minimally invasive surgical techniques and advancements in imaging and navigation technologies. The market is expected to grow at a CAGR of 10.12% during the forecast period of 2023-2031 to attain a value of USD 16.5 billion by 2031.

Image Guided Surgery Devices: Introduction

Image-guided surgery devices, also known as surgical navigation systems or surgical guidance systems, are advanced medical devices used to enhance surgical procedures by providing real-time imaging and navigation capabilities. These devices utilize imaging technologies, such as CT scans, MRI, or fluoroscopy, to create a three-dimensional virtual model of the patient's anatomy. This model is then overlaid with the real-time surgical view, allowing surgeons to visualize and navigate within the patient's body during the procedure. Image-guided surgery devices offer several uses and benefits in surgical settings.

The benefits of using image-guided surgery devices include:

  • Enhanced Precision and Accuracy: Image-guided surgery devices improve surgical precision and accuracy by providing real-time visual guidance. Surgeons can precisely locate structures, plan incisions, and navigate within complex anatomical regions, reducing the risk of errors and complications
  • Improved Patient Safety: With real-time imaging and navigation capabilities, image-guided surgery devices enhance patient safety during procedures. Surgeons can avoid critical structures, minimize tissue damage, and ensure complete removal of targeted tissues, leading to improved outcomes and reduced postoperative complications
  • Minimized Invasiveness: By facilitating precise navigation and visualization, image-guided surgery devices enable surgeons to perform minimally invasive procedures. This reduces the need for large incisions, promotes faster recovery, and reduces postoperative pain and scarring
  • Better Surgical Outcomes: The use of image-guided surgery devices can result in improved surgical outcomes. Surgeons can achieve more accurate tumour resections, better alignment in orthopaedic procedures, and optimal placement of implants, leading to improved patient outcomes and reduced revision surgeries
  • Surgical Education and Training: Image-guided surgery devices serve as valuable educational tools, allowing surgeons to gain expertise and enhance their skills. They enable trainees to practice surgical procedures in a virtual environment, improving their proficiency and confidence before performing surgeries on actual patients
It is important to note that image-guided surgery devices require specialized training for effective use. Surgeons and healthcare professionals should undergo proper training to interpret the imaging data, understand the device's functionalities, and ensure safe and accurate navigation during surgical procedures.

Image Guided Surgery Devices Market Segmentations

The market can be categorised into device type, application, and region.

Market Breakup by Device Type

  • Computed Tomography (CT)
  • Ultrasound
  • Magnetic Resonance Imaging (MRI)
  • X-Ray Fluoroscopy
  • Endoscopes
  • Positron Emission Tomography (PET)
  • Single-Photon Emission Computed Tomography (SPECT)

Market Breakup by Application

  • Neurology
  • Orthopaedic Surgery
  • Ear Nose Throat (ENT) Surgery
  • Oncology Surgery
  • Others
Image Guided Surgery Devices Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Image Guided Surgery Devices Market Overview

The image-guided surgery devices market has experienced significant growth and is projected to continue expanding in the coming years. Several factors contribute to the positive market scenario.

One of the primary drivers of market growth is the increasing adoption of minimally invasive surgical techniques. Image-guided surgery devices play a crucial role in enabling precise navigation and visualization during minimally invasive procedures. Surgeons are increasingly relying on these devices to enhance surgical accuracy, reduce invasiveness, and improve patient outcomes. The demand for image-guided surgery devices is fuelled by the growing preference for minimally invasive approaches that offer faster recovery, reduced postoperative pain, and improved cosmetic outcomes.

Moreover, technological advancements in imaging technologies and navigation systems have contributed to market expansion. The development of high-resolution imaging modalities, such as MRI, CT scans, and intraoperative ultrasound, has improved the quality of imaging data used in image-guided surgery. Additionally, the integration of advanced software algorithms and tracking systems has enhanced real-time navigation and surgical guidance capabilities. These technological innovations have increased the accuracy and reliability of image-guided surgery devices, driving their adoption in various surgical specialties.

Key Players in the Global Image Guided Surgery Devices Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the image guided surgery devices market are as follows:
  • GE Healthcare
  • Medtronic Plc
  • Olympus Corporation
  • Siemens Healthineers
  • Koninklijke Philips N.V
  • Analogic Corporation
  • Brainlab AG
  • Karl Storz Gmbh & Co. KG
  • Stryker Corporation
  • Varian Medical Systems Inc
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Image Guided Surgery Devices Market Overview
3.1 Global Image Guided Surgery Devices Market Historical Value (2016-2022)
3.2 Global Image Guided Surgery Devices Market Forecast Value (2023-2031)
4 Global Image Guided Surgery Devices Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Image Guided Surgery Devices Market Segmentation
5.1 Global Image Guided Surgery Devices Market by Device Type
5.1.1 Market Overview
5.1.2 Computed Tomography (CT)
5.1.3 Ultrasound
5.1.4 Magnetic Resonance Imaging (MRI)
5.1.5 X-Ray Fluoroscopy
5.1.6 Endoscopes
5.1.7 Positron Emission Tomography (PET)
5.1.8 Single-Photon Emission Computed Tomography (SPECT)
5.2 Global Image Guided Surgery Devices Market by Application
5.2.1 Neurology
5.2.2 Orthopedic Surgery
5.2.3 Ear Nose Throat (ENT) Surgery
5.2.4 Oncology Surgery
5.2.5 Others
5.3 Global Image Guided Surgery Devices Market by Region
5.3.1 Market Overview
5.3.2 North America
5.3.3 Europe
5.3.4 Asia Pacific
5.3.5 Latin America
5.3.6 Middle East and Africa
6 North America Image Guided Surgery Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Image Guided Surgery Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Image Guided Surgery Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Image Guided Surgery Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Image Guided Surgery Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 GE Healthcare
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Medtronic Plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Olympus Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Siemens Healthineers
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Koninklijke Philips N.V.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Analogic Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Brainlab AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Karl Storz Gmbh & Co. KG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Stryker Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Varian Medical Systems Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • GE Healthcare
  • Medtronic Plc
  • Olympus Corporation
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Analogic Corporation
  • Brainlab AG
  • Karl Storz Gmbh & Co. KG
  • Stryker Corporation
  • Varian Medical Systems Inc.

Methodology

Loading
LOADING...

Table Information